![Joseph Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Miller
Finanzdirektor/CFO bei
LB PHARMACEUTICALS INC
Vermögen: 9 Mio $ am 30.09.2026
Profil
Mr. Joseph M.
Miller, CPA, is a Chief Financial Officer at LB Pharmaceuticals, Inc. Mr. Miller was previously employed as a Chief Financial & Accounting Officer by Aurinia Pharmaceuticals, Inc., a Vice President-Finance by Sucampo Pharmaceuticals LLC, a Senior Director-Accounting by Qiagen Genomics, Inc., a Senior Director-Accounting by QIAGEN NV, a Chief Financial Officer & Vice President-Finance by Eppendorf Real Estate Corp., and a Chief Financial Officer & Vice President-Finance by Eppendorf-5 Prime, Inc. He also served on the board at Avalo Therapeutics, Inc. He received his undergraduate degree from Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.03.2026 | 576 421 ( 0,43 % ) | 9 Mio $ | 30.09.2026 |
Aktive Positionen von Joseph Miller
| Unternehmen | Position | Beginn |
|---|---|---|
| LB PHARMACEUTICALS INC | Finanzdirektor/CFO | 02.09.2026 |
Ehemalige bekannte Positionen von Joseph Miller
| Unternehmen | Position | Ende |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Finanzdirektor/CFO | 20.03.2026 |
| AVALO THERAPEUTICS, INC. | Finanzdirektor/CFO | 24.04.2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.04.2018 |
Qiagen Genomics, Inc.
 Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Comptroller/Controller/Auditor | 01.01.2015 |
| QIAGEN N.V. | Comptroller/Controller/Auditor | 01.01.2015 |
Ausbildung von Joseph Miller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Eppendorf, Inc.
 Eppendorf, Inc. BiotechnologyHealth Technology Manufactures bio-tech products | Health Technology |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Commercial Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Eppendorf-5 Prime, Inc. | |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
